Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AKAP8L | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | FAM221A | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | ATP2B3 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | PIAS2 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | PCYT1B | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | SPEN | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | PHF10 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
mRNA | ZNF736 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | SRRM3 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | USP37 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |